https://it.sputniknews.com/20211208/covid-dal-canada-arriva-un-nuovo-vaccino-nato-dalle-piante-e-efficace-al-75-per-cento-14091802.html
Kovit, a new plant-born vaccine, comes from Canada: it is 75 percent effective
Kovit, a new plant-born vaccine, comes from Canada: it is 75 percent effective
It was created by the Canadian company Medico in collaboration with the British giant GlaxoSmithKline: “75.3% effective against delta variation”.
2021-12-08T11: 52 + 0100
2021-12-08T11: 52 + 0100
2021-12-08T11: 52 + 0100
Vaccine
Corona virus worldwide
/ html / head / meta[@name=”og:title”]/ @ Content
/ html / head / meta[@name=”og:description”]/ @ Content
https://cdnnit1.img.sputniknews.com/img/07e5/09/0a/12866226_0:145:2768:1702_1920x0_80_0_0_232f018779dcdc51b258d97eb9.
Made from plants and is effective against delta variation. The new anti-govt vaccine with green technology comes from Canada. The project is being carried out by the British pharmaceutical company GlaxoSmithKline and the Quebec City company Medicaco. Therefore, the test data will soon be sent to the World Health Organization for approval. For global marketing, it is unclear whether the product is effective against the latest mutation in the Omicron virus, which has not yet appeared during research. Canadian biotech uses plants to grow virus particles, while GlaxoSmithKline provided immunity. A total of 24,000 volunteers who have been vaccinated and vaccinated in six countries, including Canada, the United States, Mexico, Great Britain, Argentina and Brazil, were involved in the study of sub-Medico. Side effects are mild or mild: in particular, fever and fatigue, which resolve within three days. “No serious adverse events were reported during the study and the rictogenicity was generally mild to moderate and transient,” the press release concludes. . Who knows if the new product will be able to vaccinate the most skeptical.
2021
Alessandra Benignetti
https://cdnnit1.img.sputniknews.com/img/07e4/09/1c/9585030_0:20:410:430_100x100_80_0_0_c93fce99e020950d5c9a6902a1651bgpg
Alessandra Benignetti
https://cdnnit1.img.sputniknews.com/img/07e4/09/1c/9585030_0:20:410:430_100x100_80_0_0_c93fce99e020950d5c9a6902a1651bgpg
News bulletin
It
https://cdnnit1.img.sputniknews.com/img/07e5/09/0a/12866226_154:0:2615:1846_1920x0_80_0_0_015911fc479ccf4d2ebe8050fdeaefcg050f.
Alessandra Benignetti
https://cdnnit1.img.sputniknews.com/img/07e4/09/1c/9585030_0:20:410:430_100x100_80_0_0_c93fce99e020950d5c9a6902a1651bgpg
Vaccine, the corona virus in the world
It was developed by the Canadian company Medico in collaboration with the British company GlaxoSmithKline: “75.3% effective against delta variation”.
Made from plants and is effective against delta variation. The new anti-Govt vaccine with technology comes from Canada Green.
The project was carried out by the British pharmaceutical company GlaxoSmithKline and the Quebec city company Medicaco.
In a report on Tuesday, the two companies said that in the third phase of the study, the vaccine achieved 71 percent effectiveness against all covariate variants and 75.3 percent against the delta variant. Is very widespread worldwide.
So, soon, the test data will be sent to the World Health Organization and accreditation for global marketing will be requested.
It is unknown at this time what he will do after leaving the post.
The system, developed by Canadian Biotech, involves the use of plants to grow virus particles, while glaxoSmithKline contributes to a chemical that strengthens the immune system, called a supplement.
The companies explain in a statement that molecules made by plants “do not contain the basic genetic material, so they are not infectious and cannot be copied”.
More than 24,000 volunteers were involved in the Medicago study, which received vaccines and placebo in six countries: Canada, the United States, Mexico, Great Britain, Argentina and Brazil.
The doses administered were at intervals of two to three weeks. Observed side effects are mild or moderate: in particular, fever and fatigue, which resolve within three days.
“No serious adverse events were reported during the study and the rictogenicity was generally mild to moderate and unstable,” the report concludes. Who knows if the new product will be able to vaccinate the most skeptical.
Leave a Reply